3.8 Review

Melatonin Treatment in Children with Developmental Disabilities

Journal

SLEEP MEDICINE CLINICS
Volume 10, Issue 2, Pages 181-+

Publisher

ELSEVIER INC
DOI: 10.1016/j.jsmc.2015.02.008

Keywords

Melatonin; Sleep; Developmental disabilities; Autism; Smith-Magenis syndrome; Angelman syndrome

Funding

  1. NIH/NIMH [R00 MH092431]
  2. NIH/NICHD [RO1 HD59253]
  3. NIH/NCRR [M01 RR00095]

Ask authors/readers for more resources

Melatonin is commonly recommended to treat sleep problems in children with developmental disabilities. However, few studies document the efficacy and safety of melatonin in these populations. This article reviews recent studies of melatonin efficacy in developmental disabilities. Overall, short treatment trials were associated with a significant decrease in sleep onset latency time for each of the disorders reviewed, with 1 notable exception-tuberous sclerosis. Reported side effects were uncommon and mild. Across disorders, additional research is needed to draw disability-specific conclusions. However, studies to date provide positive support for future trials that include larger groups of children with specific disabilities/syndromes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available